Status:
COMPLETED
Treating Post-Lyme Disease Syndrome With Acetogenins
Lead Sponsor:
Optimal Health Research
Conditions:
Post-Lyme Disease Syndrome (PLDS)
Eligibility:
All Genders
18+ years
Phase:
PHASE1
PHASE2
Brief Summary
To access the effectiveness of Acetogenins in treating Post-Lyme Disease Syndrome (PLDS).
Detailed Description
To access the effectiveness of Acetogenins in treating Post-Lyme Disease Syndrome (PLDS). After failure of antibiotic therapy to relive persistent symptoms of Lyme Disease, the use of Acetogenins to e...
Eligibility Criteria
Inclusion
- A positive Western Blot for Lyme Disease that has been treated with antibiotics but the symptoms persist post treatment.
- Must be able to swallow and mixed powder drink.
- \-
Exclusion
- Non Positive Western Blot test.
- Positive Western Blot test where the indivual has not been treated with antibiotics.
- \-
Key Trial Info
Start Date :
July 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 30 2020
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT04078841
Start Date
July 1 2019
End Date
January 30 2020
Last Update
February 11 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Optimal Health Research
Salt Lake City, Utah, United States, 84117